Related Experiment Video
Updated: Aug 18, 2026

Assembly of Cell Mimicking Supported and Suspended Lipid Bilayer Models for the Study of Molecular Interactions
Published on: August 3, 2021
Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity,
A Berquand1, N Fa, Y F Dufrêne
1Unité de Chimie des Interfaces, Université Catholique de Louvain, B-1348 Louvain-la-Neuve, Belgium.
Purpose:
To investigate the effect of a macrolide antibiotic, azithromycin, on the molecular organization of DPPC:DOPC, DPPE:DOPC, SM:DOPC, and SM:Chol:DOPC lipid vesicles as well as the effect of azithromycin on membrane fluidity and permeability.
Methods:
The molecular organization of model membranes was characterized by atomic force microscopy (AFM), and the amount of azithromycin bound to lipid membranes was determined by equilibrium dialysis. The membrane fluidity and permeability were analyzed using fluorescence polarization studies and release of calcein-entrapped liposomes, respectively.
Results:
In situ AFM images revealed that azithromycin leads to the erosion and disappearance of DPPC and DPPE gel domains, whereas no effect was noted on SM and SM:cholesterol domains. Although azithromycin did not alter the permeability of DPPC:DOPC, DPPE:DOPC, SM:DOPC, and SM:Chol:DOPC lipid vesicles, it increased the fluidity at the hydrophilic/hydrophobic interface in DPPC:DOPC and DPPE:DOPC models. This effect may be responsible for the ability of azithromycin to erode the DPPC and DPPE gel domains, as observed by AFM.
Conclusions:
This study shows the interest of both AFM and biophysical methods to characterize the drug-membrane interactions.
Insights
Azithromycin (a macrolide antibiotic) erodes DPPC and DPPE lipid domains but not SM domains in model membranes. It increases membrane fluidity without affecting permeability, highlighting its drug-membrane interaction effects.
Area of Science:
- Biophysics
- Pharmacology
- Materials Science
Background:
- Lipid bilayers are crucial for cell function.
- Understanding drug-lipid interactions is vital for drug development.
- Azithromycin is a widely used macrolide antibiotic.
Purpose of the Study:
- To investigate azithromycin's effects on model lipid membranes (DPPC:DOPC, DPPE:DOPC, SM:DOPC, SM:Chol:DOPC).
- To assess azithromycin's impact on membrane molecular organization, fluidity, and permeability.
Main Methods:
- Atomic Force Microscopy (AFM) for molecular organization.
- Equilibrium dialysis for azithromycin binding.
- Fluorescence polarization for membrane fluidity.
- Calcein-entrapped liposomes for permeability.
Main Results:
- Azithromycin eroded DPPC and DPPE gel domains but not SM or SM:cholesterol domains.
- Azithromycin did not alter vesicle permeability.
- Increased fluidity at the hydrophilic/hydrophobic interface was observed in DPPC:DOPC and DPPE:DOPC models.
Conclusions:
- Azithromycin's interaction with lipid membranes involves erosion of specific lipid domains.
- Increased membrane fluidity may explain the observed domain erosion.
- AFM and biophysical methods are valuable for characterizing drug-membrane interactions.
Related Concept Videos
Membrane Fluidity
Membrane Fluidity
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is a relatively...
Bioavailability Enhancement: Drug Permeability Enhancement
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Asymmetric Lipid Bilayer
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

